First Time Loading...

Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 65.3 NOK -0.91%
Updated: Jun 11, 2024

Intrinsic Value

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. [ Read More ]

The intrinsic value of one PHO stock under the Base Case scenario is 92 NOK. Compared to the current market price of 65.3 NOK, Photocure ASA is Undervalued by 29%.

Key Points:
PHO Intrinsic Value
Base Case
92 NOK
Undervaluation 29%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Photocure ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PHO stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Ask me anything about
Photocure ASA

Provide an overview of the primary business activities
of Photocure ASA.

What unique competitive advantages
does Photocure ASA hold over its rivals?

What risks and challenges
does Photocure ASA face in the near future?

Summarize the latest earnings call
of Photocure ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Photocure ASA.

Provide P/S
for Photocure ASA.

Provide P/E
for Photocure ASA.

Provide P/OCF
for Photocure ASA.

Provide P/FCFE
for Photocure ASA.

Provide P/B
for Photocure ASA.

Provide EV/S
for Photocure ASA.

Provide EV/GP
for Photocure ASA.

Provide EV/EBITDA
for Photocure ASA.

Provide EV/EBIT
for Photocure ASA.

Provide EV/OCF
for Photocure ASA.

Provide EV/FCFF
for Photocure ASA.

Provide EV/IC
for Photocure ASA.

Show me price targets
for Photocure ASA made by professional analysts.

What are the Revenue projections
for Photocure ASA?

How accurate were the past Revenue estimates
for Photocure ASA?

What are the Net Income projections
for Photocure ASA?

How accurate were the past Net Income estimates
for Photocure ASA?

What are the EPS projections
for Photocure ASA?

How accurate were the past EPS estimates
for Photocure ASA?

What are the EBIT projections
for Photocure ASA?

How accurate were the past EBIT estimates
for Photocure ASA?

Compare the revenue forecasts
for Photocure ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Photocure ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Photocure ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Photocure ASA compared to its peers.

Compare the P/E ratios
of Photocure ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Photocure ASA with its peers.

Analyze the financial leverage
of Photocure ASA compared to its main competitors.

Show all profitability ratios
for Photocure ASA.

Provide ROE
for Photocure ASA.

Provide ROA
for Photocure ASA.

Provide ROIC
for Photocure ASA.

Provide ROCE
for Photocure ASA.

Provide Gross Margin
for Photocure ASA.

Provide Operating Margin
for Photocure ASA.

Provide Net Margin
for Photocure ASA.

Provide FCF Margin
for Photocure ASA.

Show all solvency ratios
for Photocure ASA.

Provide D/E Ratio
for Photocure ASA.

Provide D/A Ratio
for Photocure ASA.

Provide Interest Coverage Ratio
for Photocure ASA.

Provide Altman Z-Score Ratio
for Photocure ASA.

Provide Quick Ratio
for Photocure ASA.

Provide Current Ratio
for Photocure ASA.

Provide Cash Ratio
for Photocure ASA.

What is the historical Revenue growth
over the last 5 years for Photocure ASA?

What is the historical Net Income growth
over the last 5 years for Photocure ASA?

What is the current Free Cash Flow
of Photocure ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Photocure ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Photocure ASA

Current Assets 372.4m
Cash & Short-Term Investments 259.5m
Receivables 75.7m
Other Current Assets 37.2m
Non-Current Assets 338.8m
PP&E 33.5m
Intangibles 256.5m
Other Non-Current Assets 48.8m
Current Liabilities 77.5m
Accounts Payable 19.7m
Other Current Liabilities 57.9m
Non-Current Liabilities 151.6m
Other Non-Current Liabilities 151.6m
Efficiency

Earnings Waterfall
Photocure ASA

Revenue
500.7m NOK
Cost of Revenue
-26.1m NOK
Gross Profit
474.5m NOK
Operating Expenses
-446.7m NOK
Operating Income
27.8m NOK
Other Expenses
-27.5m NOK
Net Income
267k NOK

Free Cash Flow Analysis
Photocure ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PHO Profitability Score
Profitability Due Diligence

Photocure ASA's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Positive Revenue Growth Forecast
38/100
Profitability
Score

Photocure ASA's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

PHO Solvency Score
Solvency Due Diligence

Photocure ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
78/100
Solvency
Score

Photocure ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHO Price Targets Summary
Photocure ASA

Wall Street analysts forecast PHO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHO is 100.98 NOK with a low forecast of 85.85 NOK and a high forecast of 131.25 NOK.

Lowest
Price Target
85.85 NOK
31% Upside
Average
Price Target
100.98 NOK
55% Upside
Highest
Price Target
131.25 NOK
101% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PHO Price
Photocure ASA

1M 1M
+8%
6M 6M
+4%
1Y 1Y
+26%
3Y 3Y
-56%
5Y 5Y
+48%
10Y 10Y
+169%
Annual Price Range
65.3
52w Low
40.85
52w High
70.9
Price Metrics
Average Annual Return 30.92%
Standard Deviation of Annual Returns 49.65%
Max Drawdown -73%
Shares Statistics
Market Capitalization 1.8B NOK
Shares Outstanding 26 943 800
Percentage of Shares Shorted
N/A

PHO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Photocure ASA Logo
Photocure ASA

Country

Norway

Industry

Pharmaceuticals

Market Cap

1.8B NOK

Dividend Yield

0%

Description

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

Contact

OSLO
Oslo
Hoffsveien 4
+4722062210.0
https://www.photocure.com/

IPO

2000-05-29

Employees

89

Officers

President & CEO
Mr. Daniel Schneider
Chief Financial Officer
Mr. Erik Dahl
Head of Investor Relations
Mr. David Moskowitz
Chief Medical Officer of Global Medical Affairs, Clinical Development and R&D
Dr. Anders Neijber M.D.
Group Controller
Mr. Tolv Hillestad

See Also

Discover More
What is the Intrinsic Value of one PHO stock?

The intrinsic value of one PHO stock under the Base Case scenario is 92 NOK.

Is PHO stock undervalued or overvalued?

Compared to the current market price of 65.3 NOK, Photocure ASA is Undervalued by 29%.